Absolutely, there is a ton of interest in the Vision trial results. We then have the final LuPIN results to be announced around October.
Should the Vision trial results show similar mOS, it would then be interesting to know the details of the co-sponsoring arrangement with Novartis. At a minimum I expect Novartis to help fund the P2 trials, but would a more significant agreement also be entered into prior to commencing these trials? Good times ahead.
Add to My Watchlist
What is My Watchlist?
